Answers - Finance

In mid September, Mitchell Dong, chief investment officer of Solios Asset Management told a news wire service, “I think we are seeing the tip of the iceberg of financial investors entering the physical uranium market.” At the Platts Nuclear Fuel Strategies conference in Washington, this past week, Mitchell Dong was a pit bull. Not only did he take extensive notes during the speeches, but he was first-in-line to question the majority of the speakers after their presentations.

Clearly, whatever initial purchases his fund or funds had made, in entering the physical uranium and

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

equities markets, he probably wasn’t finished loading up. Nearby, a trio of Greenwich, Connecticut hedge fund managers quietly listened to the presentations. Later, they lunched alone at their table while we observed them huddled in deep discussions about what bets they might place in the uranium bull market.

Long-time insiders have kept trying to put this bull market into whatever context they could. A difficult task since many of them endured a twenty-plus-year uranium drought, which only came out of hibernation the past few years. Some admitted they had nearly given up

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

n the sector as the years passed by. Now, they and everyone else involved is trying to figure out how to make the Big Score on this amazing nuclear renaissance.

Of course there were opposing views on how to deal with the uranium price. Charles Peterson, an attorney at DC-based Pillsbury Winthrop Shaw Pittman LLP, hinted at a more transparent market, hoping uranium might be offered on a future exchange. He compared to the accessibility of other metals where traders use speculators. Later in the day, Patricia Mohr, Vice President for Economics, at Canada’s Scotiabank warned t

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

e industry that if uranium were traded on a futures market, its volatility might already have it trading at $100/pound.

Again, the uranium price worried many at the conference. Ending the HEU hung around at the back of the minds of utility executives probably because many wondered where future SWU would come from, should the Russians terminate supplies to U.S. utilities. Should preparations not be taken at this time, it would not surprise us to see a super-spike in the price of uranium which Sprott Asset Management’s Kevin Bambrough has occasionally warned us about. U.S. ut

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

lities remain complacent, assured the Department of Energy will come to the rescue at the last minute. But will they?

On the outside chance we might get insights into the complex and secretive Russian mind, we cornered Andrey A. Orekhov, counselor for the Science and Technology Department at the Embassy of the Russian Federation. He briefly attended the conference to eavesdrop on what Ronald Lorentzen, Director of the Office of Policy within the U.S. Department of Commerce, had to say at his presentation with regards to ongoing Russo-U.S. negotiations. We tested the waters

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

y talking about the new generation of nuclear reactors, and brashly asking him if he could introduce us to Sergei Kirienko, head of Russia’s atomic energy agency, Rosatom. Instead he referred us to a lesser light for an interview.

Then, we asked him if we had been accurate in reporting that Russia’s aggressive nuclear ambitions would drive the uranium price to $100/pound. Pondering our question for a while, as if weighing whether the wrong answer would lead to his next meal in a Russian prison, Orekhov looked off into a far corner of the room and responded, “Who knows?”

Hi

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

s question concisely summarized the collective thoughts of the conference. No one really knows how much higher the price of uranium will run, whether it will reach $100/pound (and higher) and how soon it might arrive at the century mark. As we noted in an earlier part of this series, Dustin Garrow remarked of a possible run to the $80 to $100/pound level. The Florida Power and Light spokesman believed $52/pound was too high.

Renaissance Could Hit a Wall

Garrow made an interesting point at the beginning of his presentation, announcing, “There are now more than 400 uranium c

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

mpanies.” The implications of his comment are wide-ranging should one pause to ponder what he meant. Fuel Cycle Week senior editor Nancy Roth addressed this in the October 3rd issue. She reported upon the events and revelations at the Platts conference, writing, “Several speakers mentioned serious technology and equipment deficits that are a legacy of this dormant period (the uranium depression: 1980 – 2003), along with the dearth of nuclear personnel from uranium miners to nuclear engineers.”

These observations swipe at both sides: uranium producers and utility end-users o

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

the uranium. If the labor and equipment shortages fail to provide sufficient uranium for utilities, then the price is likely to rise much higher. At the same time, should nuclear power plants fail to staff up their operations, or construction delays impact the building of new reactors, a lesser quantity of supply, less than what has been projected, will be required.

To make it short and simple: this industry is still too ‘new’ to realize all of the complications required to move forward. As Ms. Roth wrote in an email to us, “I think the uranium industry has a real chicken-

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

nd-egg problem in reinventing itself, and I think a key indicator of the severity of the problem might be in these production costs.” The cost to which she was referring was the expense required to extract uranium from the ground. In the United States, there are a handful of in situ recovery operations. That is an insufficient number to adequately calculate an average production cost for a mining operation.

What happens when another half dozen uranium properties commence new mining operations? One of the hidden problems within the uranium development sector is the lack of p

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

oven miners. Over the past year, a few existing U.S. uranium producers experienced employee raids by the newly arrived development companies. We suspect more will take place, as several companies move closer to the mine development stage. Raids are taking place because of a lack of skilled and proven personnel.

Patricia Mohr brought up another of many interesting points. Increased mining output during 2004 and 2005, but in the first half of 2006 Mohr observed, “Mine production probably dropped in the first half of 2006.” She believes production was about 20 percent of compa

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

nies planned. She pointed out Australia’s Ranger mine production was lower because of a cyclone; Olympic Dam because of declining ore grades. Rugged granite, from which Namibian uranium is mined, has reportedly caused problems at this country’s Rossing mine. Mohr believes the mine’s output could slow down in the second half of the year.

We believe the production costs for many of the up-and-coming projects are going to be greater than expected. When was the last time a new uranium mill was built? Not in this century. When was the last great uranium deposit discovered? Twent

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

years ago. How does a new company calculate its start-up and operating mining and milling costs in today’s dollars? Some might believe they know the answer, but we won’t really know until the actual production scenario takes place. And that might be two years down the road at the very earliest. Factors such as those do puzzle the forecasters, the analysts and the industry insiders. They truly do not have a proven benchmark against which to make an accurate evaluation. The last time they could was during the uranium bull market of the 1970s.

What about those 400 uranium com

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

anies? “Do you read their news releases?” asked Nancy Roth. She does, we read many of them. “Aren’t most of them just hype?” she inquired. We had to agree with her assessment. But in understanding the junior uranium companies, it is the news release which attracts investors to provide market support for their stock prices. Some have no real plans but to mine the stock market, as author and long-time uranium insider Julian Steyn once told us. Over dinner, Ms. Roth provided us with an important insight. She covers the NRC hearings for various companies hoping to move their pro

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ects forward. Those who are actually meeting with NRC aren’t doing so for a free trip to Washington at the expense of their shareholders, but instead to bring their project into the mine development stage. Among the most recent applicants were some of our favorites, such as Uranerz Energy (AMEX: URZ), UR-Energy (TSX: URE) and Energy Metals (TSX: EMC). Another was the privately held Concentric Energy Corp.

Coincidentally, StockInterview fan Laura Stein had been emailing us to meet with Ralph Kettell, Chief Executive of Concentric Energy. Because of Ms. Stein’s insistence, an

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

our review of Mr. Kettell, we met with him about his project. Aptly, he chose the Greenbelt exit on the Baltimore-Washington Parkway. For those unfamiliar with this exit, it is the road to NASA. As an electrical engineer, it was for NASA that Kettell designed the radio frequency (RF) portion of the Space to Space Communications System used in the construction of the International Space Station. Kettell also likes to seriously dabble in natural resource stocks, having been the lead investor and a director in AuEx Ventures.

No stranger to the uranium market, he had written a

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

n article for a resource website in 2003, proclaiming the coming bull market in uranium. Kettell forecast that some of his favorite stock picks, such as Strathmore Minerals – then trading for about C$0.30/share, would jump by 1000 percent. Strathmore’s 2006 high was C$3.00.

Kettell had created an index of five uranium stocks (there weren’t 400 to choose from, back in 2003) from which he started at a base number of 100. Kettel’s favorite stocks were Cameco Corp (NYSE: CCJ), Denison (TSX: DEN), International Uranium Corp (TSX: IUC), JNN Resources (TSX: JNR) and Strathmore Min

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

rals (TSX: STM). He told us this past spring, the value of his index had soared to the 3,000 level – up 30 times from when he began tracking his favorite uranium stocks. Since then, the index had dropped to 2,200. We asked him in which direction he believed it was heading next. He responded, “I’ve looked at the technicals (technical analysis), and it should blow through the 3,000 level in 2007.”

By early 2007, Kettell believes his private company, Concentric Energy, should be publicly trading. He told us he had rounded up the support of Jim Dines, Doug Casey and other newsl

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

tter writers for his private placement stock. Kettell said Pinetree Capital (TSX: PNP) was one institution backing his project. His company plans to develop the Anderson uranium mine, about 75 miles northwest of Phoenix, Arizona. The property had produced about 33,000 pounds in the 1950s. Additional exploration by Unocal and Urangesellschaft in the late 1970s demonstrated sufficient promise in the property. He told us Unocal was planning a 2,000-ton-day mill in 1978 for a proposed open pit mine.

We mention this meeting to bring home a very strong point about the future pric

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

of uranium. Upon our asking Mr. Kettell what his operating costs for the milling and mining operations at the Anderson property, he told us, “About $65/pound.” At least he was honest. This may not be the price level U.S. utilities want to hear about, but it might become the floor price for the future price of uranium. Perhaps, Mr. Kundalkar, the vice president from Florida Power and Light whom we mentioned during the first article in this series, should pay attention to what the uranium miners are saying. We are.

COPYRIGHT © 2007 by StockInterview, Inc. ALL RIGHTS RESERVED

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/102867/answers-Uranium-Bull-Market-Only-Tip-of-the-Iceberg.html">Uranium Bull Market: Only Tip of the Iceberg</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/102867/answers-Uranium-Bull-Market-Only-Tip-of-the-Iceberg.html]Uranium Bull Market: Only Tip of the Iceberg[/url]

Bar code label software is used to print symbols on bar codes. This software can render a pattern of black stripes and dots, each unique from the other, which is used to print bar code stickers. The software prints intricate patterns for each product. The pattern may be several black lines of different thicknesses or it may be a crisscross arrangement of thick and thin black dots.

There is a certain amount of trust required to take out your credit card and give money to someone you don't know. And while security is MUCH better than in previous years, it would still behoove us to present as professional image as possible when dealing with our customers.

Breaking in to the major search engines can be a long grueling process, but it does not have to be that bad. Here are ten great tips!

Tags

Links

Answers - Uranium Bull Market: Only Tip of the Iceberg

Related Articles: